Delivery Order SPE2DX22D0010-SPE2D826FAT61
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Methylphenidate ER (extended-release) tablets at 54mg dosage. This firm fixed-price delivery order, valued at $6,673.17, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, valued at $4,817.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $2,071.52. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylphenidate Extended-Release 36 mg tablets in quantities of 100 units. This contract, valued at $1,697.25, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The delivery order was...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Methylphenidate ER 18 mg tablets in quantities of 100 units. This is a firm fixed price delivery order with a ceiling value of $1,821.03 and an ultimate completion date of August 7, 2025. The contract carries no set-aside designation and was competitively awarded. The place of performance is the contractor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate extended-release tablets (54mg) with a ceiling value of $6,043.30. This is a firm fixed-price delivery order issued on October 29, 2025, with an ultimate completion date of October 30, 2025. The award carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the contractor's location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER tablets 54 mg on October 2, 2025, with a firm fixed price contract value of $1,221.15 and an ultimate completion date of October 3, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement to support federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100, with a contract ceiling value of $1,224.06. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER 36mg tablets (100-count) with a ceiling value of $5,179.68. This non-competitive, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of the same day. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAT61Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Methylphenidate ER (extended-release) brand-name tablets at 72mg strength. This firm fixed-price delivery order is valued at $6,334.55 with an ultimate completion date of November 3, 2025. The contract is not set-aside and was competitively awarded to the prime contractor, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply comprehensive pharmaceutical products and medical supplies across multiple therapeutic domains through open competition. As a child order under the DLA Troop Support Medical IDC, this delivery order represents one of numerous pharmaceutical transactions fulfilling the broader global pharmaceutical support vehicle that enables the company to supply military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 10/31/25 |